4.2 Article

Toward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions

Journal

PERSONALIZED MEDICINE
Volume 14, Issue 3, Pages 235-247

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/pme-2016-0089

Keywords

3Gb; cost-effectiveness analysis; diagnosis; economic evaluation; genomics; health technology assessment; next-generation sequencing; resource allocation; whole-genome sequencing

Funding

  1. European Union [602269]

Ask authors/readers for more resources

Whole-genome sequencing (WGS) is being applied within research settings across Europe to develop genomic WGS-based diagnostic tests. The focus of this perspective paper is to describe if, and how, current approaches of health technology assessment could be applied to WGS-based diagnostic tests. This perspective draws on the collective view from a trans-European multidisciplinary consortium of methodologists, clinicians and scientists. Specific challenges can be described by using the PICO (population, intervention, comparator, outcome) framework to inform health technology assessment. Practical solutions are suggested which require joined-up, multidisciplinary working across healthcare systems using existing expert networks so that emergent issues for the health technology assessment of WGS can be met in a timely fashion.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available